Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02372175 · ClinicalTrials.gov registry record · Phase 1
Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain
A Phase 1 study, sponsored by U.S. Army Medical Research and Development Command.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT02372175 is a Phase 1 study that has completed, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 27 participants.
The verdict
NCT02372175, a Phase 1 study, has completed, sponsored by U.S. Army Medical Research and Development Command.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
To evaluate the effectiveness of candidate dengue vaccine formulations, it is prudent to develop an appropriate challenge model. To this end, this first-in-human study will examine the safety and effectiveness of the Dengue 1 Live Virus Human Challenge (DENV-1-LVHC) product and assess the ability of this virus strain to elicit an uncomplicated dengue-like illness.
Interventions
- BIOLOGICAL Dengue-1 Virus-Live Virus Human Challenge (DENV-1-LVHC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2015-10 |
| Est. Completion | 2019-06-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02372175
The ClinicalTrials.gov registry entry for NCT02372175 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is U.S. Army Medical Research and Development Command, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dengue-1 Virus-Live Virus Human Challenge (DENV-1-LVHC) is the first listed.
NCT02372175 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02372175 about?
NCT02372175 is a clinical study titled "Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain". To evaluate the effectiveness of candidate dengue vaccine formulations, it is prudent to develop an appropriate challenge model. To this end, this first-in-human study will examine the safety and effectiveness of the Dengue 1 Live Virus Human Challenge (DENV-1-LVHC) product and assess the ability of...
What is the current status of trial NCT02372175?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2015-10. Estimated completion is 2019-06-28.
What interventions are being tested in trial NCT02372175?
The interventions under investigation include: Dengue-1 Virus-Live Virus Human Challenge (DENV-1-LVHC) (BIOLOGICAL).
Who is sponsoring clinical trial NCT02372175?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.